Overview


According to FutureWise analysis the market for neonatal intensive care in 2023 is US$ 7.41 billion, and is expected to reach US$ 11.15 billion by 2031 at a CAGR of 5.24%.

Premature infants with low birth weight, perinatal issues, congenital abnormalities, respiratory illnesses, neuromuscular diseases, or who have had thoracoabdominal surgery are cared for in neonatal intensive care units (NICUs). For the specific needs of newborn infants, NICUs are equipped with cutting-edge life support systems and a team of highly qualified professional medical and nursing staff. The neonatal intensive care unit (NICU) is a specific area of the hospital where new-borns who require intensive medical care are frequently placed. Babies that are not as unwell but still require specialized nursing care may also receive care in NICUs.

Physical therapists have been shown to be helpful in the NICU in lowering physical limits and impairments in infants and educating the family on how to care for their newborn in the best way. Parent education and collaboration are crucial regarding NICU physiotherapy and invasive procedures used in the NICU. One of the most difficult duties is newborn monitoring. The management of neonatal health concerns has continued to depend on developing better equipment. Manufacturers are investing significantly to meet the rising demand for neonatal critical care equipment, notably thermoregulation devices.

FutureWise Market Research has published a report that provides an insightful analysis of neonatal intensive care market trends that are affecting the overall market growth. This report will provide a detailed analysis of market share, regional insights, and competitor analysis that includes stature of key manufacturers operational in this industry.

According to the analysis conducted by FutureWise research analysts, the neonatal intensive care market is estimated to register a considerable growth rate over the forecast period. This report lists the market segments and potential prospects available across this industry, in addition providing crucial information on the total valuation currently held by the industry. Moreover, this report will assist key management individuals in an organisation to enhance their decisions pertaining to business expansion as well as strategic changes for increasing customer base.

  • Cook Medical
  • C. R. Bard, Inc.
  • Angiodynamics
  • Teleflex Incorporated
  • B. Braun Melsungen AG
  • Becton, Dickinson and Company
  • Medtronic
  • Vygon (UK) Ltd
  • Utah Medical Products
  • Smiths Medical
  • Phoenix medical Systems
  • Koninklijke Philips N.V
  • Digicare Biomedical Technologies Inc
  • GE Healthcare

(Note: The list of the major players will be updated with the latest market scenario and trends)

Recent developments by key players in Neonatal Intensive Care Market:

In June 2022-Dräger was chosen by Frost & Sullivan for its 2022 Global New Product Innovation Leadership Award in the respiratory care and neonatal care categories.

Neonatal hypothermia is the term used to describe a fall in the newborn's body temperature. The neonatal intensive care unit (NICU) provides medical attention to infants born prematurely or with a disease requiring treatment. Low birth weight babies and incidences of neonatal hypothermia are both rising, fueling market expansion. Preterm births are on the rise, and several variables affect the newborn's status, including the mother's health, diabetes, drug, and alcohol abuse, and many pregnancies. In addition, the market is anticipated to grow due to COVID-19 infections and other respiratory conditions among newborns. Moreover, the need for highly specialized newborn care equipment has grown due to technological advancements in both developed and developing countries. The emergence of inventive incubators and incubators that can be used with MRIs, projected to enhance treatment for preterm infants, will certainly cause the market for neonatal care equipment to expand quickly. Furthermore, key player cooperation in providing highly improved NICUs and rising healthcare providers' awareness of NICU equipment advancements is anticipated to fuel market growth. However, the inaccessibility of newborn care equipment in emerging nations is also projected to limit market growth. The market's growth is also constrained by a lack of awareness, economic limitations in developing nations, and declining birth rates in developed nations.

By Product Type

  • Peripheral Catheters
    •    Peripheral Intravenous Catheters (PIVC)
    •    Midline Catheters (Extended Dwell)
  • Central Catheters
    •    Peripherally Inserted Central Catheters (PICC)
    •    Central Venous Catheters (CVC)
    •    Implantable Ports
    •    Umbilical Catheters
  • Introducers & Accessories
    •  Subcutaneous
    •  Intravenous

By Application  

  • Medication Administration
  • Transfusion of Blood
  • Diagnostic Testing
  • Feeding

By End-user

  • Hospitals
  • Clinics
  • Ambulatory Surgical Centers

By Region

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa

This market research report also emphasis on factors affecting the growth rate in various regions listed above. A deep-down analysis of region will also be provided in the final version of this market which is based on conclusion of primary interviews and secondary data point gathered during the process.

By region, the market is segmented into North America, Latin America, Europe, Asia-Pacific, and Middle East & Africa. North America registered highest share in the market in 2022. This might be ascribed to the availability of established healthcare facilities and increased demand for cutting-edge medical technology. The value-based healthcare model has promoted the expansion of highly specialized NICU centers as the number of technologies permitted by regulatory authorities has expanded. Throughout the analysis period, the increase in newborn fetal fatalities in the area is anticipated to support market expansion. For instance, according to the CDC report from August 2021, between 2% and 10% of pregnancies in the United States are influenced by gestational diabetes. As a result, the market is flourishing due to the rising need for neonatal intensive care for the treatment of gestational diabetes

  • Tier 1 players- established companies in the market with a major market share
  • Tier 2 players
  • Emerging players which are growing rapidly
  • New Entrants

  •  Growth prospects
  •  SWOT analysis
  •  Key trends
  •  Key data-points affecting market growth

  • To provide with an exhaustive analysis on the Neonatal Intensive Care Market By Product Type, By Application, By End-user and By Region.
  • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
  • To evaluate and forecast micro-markets and the overall market
  • To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
  • To record and evaluate competitive landscape mapping- product launches, technological advancements, mergers and expansions

  • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
  • The customization Mobility Care offered are free of charge with purchase of any license of the report
  • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents


  • 1.   Market Introduction
    •   1. Objectives of the Study
        2. Market Definition
        3. Market Scope
         3.1 . Years Considered for the Study
         3.2 . Market Covered
        4. Currency
        5. Limitations
        6. Stakeholders
  • 2.   Research Methodology
    •   1. Research Data
         1.1 . Secondary Data
          1.1.1 . Key Data from Secondary Sources
         1.2 . Primary Data
          1.2.1. Key Data from Primary Sources
        2. Market Size Estimation
        3. Market Breakdown and Data Triangulation
        4. Assumptions for the Study
  • 3.   Executive Summary
    •   1. Market Outlook
        2. Segment Outlook
        3. Competitive Insights
  • 4.   Global Neonatal Intensive Care Market Variables, Trends and Scope
    •        1. Market LineProducts Outlook
        2. Penetration and Growth Prospect Mapping
        3. Industry Value Chain Analysis
        4. Cost Analysis Breakdown
        5. Technology Overview
        6. Regulatory Framework
         6.1. Reimbursement Framework
         6.2. Standards and Compliances

  • 5.   Market Overview
    •   1. Market Dynamics
         1.1. Market Driver Analysis
          1.1.1. Increasing focus of Neonatal Intensive Care Companies on Brand Protection
          1.1.2. Untapped Opportunities in Emerging Regions
         1.2. Market Restraint Analysis
          1.2.1. High Cost Associated with Implementation of Predictive Analysis
         1.3. Industry Challenges
          1.3.1. Presence of Ambiguous Regulatory Framework
  • 6.   Global Neonatal Intensive Care Market Analysis Tools
    •   1. Industry Analysis - Porter’s
         1.1. Supplier Power
         1.2. Buyer Power
         1.3. Substitution Threat
         1.4. Threat from New Entrants
         1.5. Competitive Rivalry
        2. Pestel Analysis
         2.1. Political Landscape
         2.2. Environmental Landscape
         2.3. Social Landscape
         2.4. Technology Landscape
         2.5. Legal Landscape
        3. Major Deals And Strategic Alliances Analysis
         3.1. Joint Ventures
         3.2. Mergers and Acquisitions
         3.3. Licensing and Partnership
         3.4. Technology Collaborations
         3.5. Strategic Divestments
        4. Market Entry Strategies
        5. Case Studies
  • 7.   Global Neonatal Intensive Care Market, By Product Type Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Peripheral Catheters
         1.1. Peripheral Intravenous Catheters (PIVC)
         1.2. Midline Catheters (Extended Dwell)
        2. Central Catheters
         2.1. Peripherally Inserted Central Catheters (PICC)
         2.2. Central Venous Catheters (CVC)
         2.3. Implantable Ports
         2.4. Umbilical Catheters
        3. Introducers and Accessories
         3.1. Subcutaneous
         3.2. Intravenous

  • 8.   Global Neonatal Intensive Care Market, By Application Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Medication Administration
        2. Transfusion of Blood
        3. Diagnostic Testing
        4. Feeding

  • 9.   Global Neonatal Intensive Care Market, By End-user Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Hospitals
        2. Clinics
        3. Ambulatory Surgical Centers

  • 10.   North America Neonatal Intensive Care Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. U.S.A
         2.2. Canada
         2.3. Mexico
        3. Market Size (USD Million) Forecast for North America 2023-2031

  • 11.   Latin America Neonatal Intensive Care Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Brazil
         2.2. Venezuela
         2.3. Argentina
         2.4. Rest of Latin America
        3. Market Size (USD Million) Forecast for Latin America 2023-2031

  • 12.   Europe Neonatal Intensive Care Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Germany
         2.2. U.K
         2.3. France
         2.4. Italy
         2.5. Spain
         2.6. Russia
         2.7. Poland
         2.8. Rest of Europe
        3. Market Size (USD Million) Forecast for Europe 2023-2031

  • 13.   Asia Pacific Neonatal Intensive Care Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Japan
         2.2. China
         2.3. India
         2.4. Australia and New Zealand
         2.5. ASEAN
         2.6. Rest of Asia Pacific
        3. Market Size (USD Million) Forecast for Asia Pacific 2023-2031

  • 14.   Middle East and Africa Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. GCC
         2.2. Israel
         2.3. South Africa
         2.4. Rest of MEA
        3. Market Size (USD Million) Forecast for MEA 2023-2031

  • 15.   Market Share Analysis and Competitive Landscape
    •   1. Global Landscape - Key Players, Revenue and Presence
        2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
        3. Global Emerging Companies
        4. North America - Market Share Analysis and Key Regional Players
        5. Europe - Market Share Analysis and Key Regional Players
        6. Asia Pacific - Market Share Analysis and Key Regional Players
        7. Global Key Player - Growth Matrix
  • 16.   Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)
    •   1. Cook Medical
         1.1. Company Overview
         1.2. Product Portfolio
         1.3. SWOT Analysis
         1.4. Financial Overview
         1.5. Strategic Overview
        2. C. R. Bard, Inc.
         2.1. Company Overview
         2.2. Product Portfolio
         2.3. SWOT Analysis
         2.4. Financial Overview
         2.5. Strategic Overview
        3. Angiodynamics
         3.1. Company Overview
         3.2. Product Portfolio
         3.3. SWOT Analysis
         3.4. Financial Overview
         3.5. Strategic Overview
        4. Teleflex Incorporated
         4.1. Company Overview
         4.2. Product Portfolio
         4.3. SWOT Analysis
         4.4. Financial Overview
         4.5. Strategic Overview
        5. B. Braun Melsungen AG
         5.1. Company Overview
         5.2. Product Portfolio
         5.3. SWOT Analysis
         5.4. Financial Overview
         5.5. Strategic Overview
        6. Becton, Dickinson and Company
         6.1. Company Overview
         6.2. Product Portfolio
         6.3. SWOT Analysis
         6.4. Financial Overview
         6.5. Strategic Overview
        7. Medtronic
         7.1. Company Overview
         7.2. Product Portfolio
         7.3. SWOT Analysis
         7.4. Financial Overview
         7.5. Strategic Overview
        8. Vygon (UK) Ltd
         8.1. Company Overview
         8.2. Product Portfolio
         8.3. SWOT Analysis
         8.4. Financial Overview
         8.5. Strategic Overview
        9. Utah Medical Products
         9.1. Company Overview
         9.2. Product Portfolio
         9.3. SWOT Analysis
         9.4. Financial Overview
         9.5. Strategic Overview
        10. Smiths Medical
         10.1. Company Overview
         10.2. Product Portfolio
         10.3. SWOT Analysis
         10.4. Financial Overview
         10.5. Strategic Overview
        11. Phoenix medical Systems
         11.1. Company Overview
         11.2. Product Portfolio
         11.3. SWOT Analysis
         11.4. Financial Overview
         11.5. Strategic Overview
        12. Koninklijke Philips N.V
         12.1. Company Overview
         12.2. Product Portfolio
         12.3. SWOT Analysis
         12.4. Financial Overview
         12.5. Strategic Overview
        13. Digicare Biomedical Technologies Inc
         13.1. Company Overview
         13.2. Product Portfolio
         13.3. SWOT Analysis
         13.4. Financial Overview
         13.5. Strategic Overview
        14. GE Healthcare
         14.1. Company Overview
         14.2. Product Portfolio
         14.3. SWOT Analysis
         14.4. Financial Overview
         14.5. Strategic Overview

  • 17.   Pre and Post COVID-19 Impact
    •   1. Positive influence on the healthcare industry
        2. The financial disruption of the manufacturing sector
        3. Impact of COVID-19 on emerging companies
        4. Significant mandates in the healthcare regulations initiated by
                  administrations
        5. The overall economic slowdown of the developing and developed nations

  • 18.   FutureWise SME Key Takeaway Points for Client
Partner

Our Clients